LAUREN TAMPLIN: Open Payments
NPI 1700882446 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,445 in 102 payments from 14 companies in 2025. Trend: 2023 $1,477 · 2024 $2,206 · 2025 $2,445
Food & beverage: $2,445
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 20 | $662 |
| GlaxoSmithKline, LLC. | 23 | $459 |
| AstraZeneca Pharmaceuticals LP | 13 | $290 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $173 |
| Novartis Pharmaceuticals Corporation | 6 | $152 |
| Amgen Inc. | 8 | $142 |
| Grifols USA, LLC | 7 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $119 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| CSL Behring | 3 | $89 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, NEFFY, Xembify, Rhapsido, CUVITRU, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
